|
|
Volumn 13, Issue 4, 2001, Pages 417-428
|
|
Optimising drug development: Strategies to assess drug metabolism/transporter interaction potential - Towards a consensus
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASTEMIZOLE;
CISAPRIDE;
DEXTROMETHORPHAN;
FURAFYLLINE;
MIBEFRADIL;
MIDAZOLAM;
OMEPRAZOLE;
RIFAMPICIN;
SORIVUDINE;
TERFENADINE;
DRUG;
CONFERENCE PAPER;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG INTERACTION;
DRUG METABOLISM;
DRUG TRANSPORT;
DRUG WITHDRAWAL;
FOOD AND DRUG ADMINISTRATION;
MARKET;
METHODOLOGY;
PHARMACEUTICS;
PRIORITY JOURNAL;
CHEMISTRY;
DECISION MAKING;
DRUG CONTROL;
DRUG DESIGN;
HUMAN;
METABOLISM;
PHYSIOLOGY;
STANDARD;
SYNTHESIS;
TRANSPORT AT THE CELLULAR LEVEL;
BIOLOGICAL TRANSPORT;
CHEMISTRY, PHARMACEUTICAL;
DECISION MAKING;
DRUG AND NARCOTIC CONTROL;
DRUG DESIGN;
DRUG INTERACTIONS;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
RESEARCH DESIGN;
|
|
EID: 0034963603
PISSN: 09280987
EISSN: None
Source Type: Journal
DOI: 10.1016/S0928-0987(01)00148-8 Document Type: Conference Paper |
|
Times cited : (40)
|
|
References (0)
|
